Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis

J Neuroimmunol. 2013 Jun 15;259(1-2):1-7. doi: 10.1016/j.jneuroim.2013.02.020. Epub 2013 Mar 26.

Abstract

To extend our studies on glycolipid-reactive invariant Natural Killer T-cell (iNKT-cell) function in multiple sclerosis (MS), we investigated the stimulatory activities of two myelin-derived glycolipids that are poly-acetylated derivatives of β-galactosylceramide designated as fast-migrating cerebrosides (FMC) by thin-layer chromatography. In healthy subjects, FMC stimulation of peripheral blood cells significantly expanded iNKT-cells similar to α-GalCer and induced significant increases in Th1, Th2 and Th17 cytokines. In marked contrast, MS patients failed to respond to FMCs or to α-GalCer stimulation indicating an anergic response. We propose that myelin-derived FMC glycolipids stimulate iNKT-cell responses in vivo and this is blocked in MS.

MeSH terms

  • Adult
  • Aged
  • Carbohydrate Sequence
  • Cerebrosides / chemistry
  • Cerebrosides / metabolism
  • Clonal Anergy / immunology*
  • Female
  • Flow Cytometry
  • Galactosylceramides / chemistry
  • Galactosylceramides / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Multiple Sclerosis, Chronic Progressive / immunology*
  • Multiple Sclerosis, Relapsing-Remitting / immunology*
  • Myelin Sheath / metabolism*
  • Natural Killer T-Cells / immunology*
  • Natural Killer T-Cells / metabolism*
  • Neuroimmunomodulation / immunology
  • Young Adult

Substances

  • Cerebrosides
  • Galactosylceramides
  • alpha-galactosylceramide